The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
of the student body are women
among universities worldwide for producing undergrad entrepreneurs
companies founded by graduates and faculty in the last 10 years
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesDiscover ways to support, connect, and help drive innovation.
Get InvolvedExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs Seen in BSF.org
Researchers at the Technion Faculty of Biology have identified potential new innovative genetic therapies for cancer and brain diseases.
The findings were supported by the Israel Science Foundation (ISF), the US-Israel Binational Science Foundation (BSF), NSF-BSF Molecular and Cellular Biosciences, and the National Institutes of Health (NIH) and were published in the peer-reviewed journal Nucleic Acids Research.
The study was conducted in collaboration with the research group of Professor Heather Hundley from Indiana University and was led by Ph.D student Berta Eliad, master’s student Noa Schneider, and their advisor, Associate Professor Ayelet Lamn.
by
www.bsf.org.il (opens in a new tab)
on
November 22, 2024
Technion researchers have identified potential new innovative genetic therapies for cancer and brain diseases.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Faculty / Biotech / Cancer / Healthy Aging / Intelligent Drugs / Neurological Diseases /
An Israeli medical researcher has helped shed new light on a mystery that has endured for nearly 340 years: what killed Queen Christina of Sweden, one of 17th-century Europe’s most unusual monarchs. Prof. Zaid Abassi of the Technion – Israel Institute of Technology’s, Ruth and Bruce Rappaport Faculty of Medicine and Rambam Health Care Campus, […]
Artificial intelligence is rapidly becoming an integral part of our lives, and a working tool for professionals in a variety of fields, including medicine, which integrates AI in order to reach faster, more accurate, and more efficient diagnoses. But to what extent can AI truly be relied upon when it comes to complex medical decisions? […]
Few medical decisions seem so simple, yet create so much uncertainty: Is the infection bacterial, and therefore potentially in need of antibiotics, or viral, meaning antibiotics will not help? For years, physicians have tried to answer that question using symptoms, blood tests and tests that directly search for the virus or bacteria. Israeli company MeMed […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.